Trieu Vuong - Dec 6, 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Dec 6, 2022
Transactions value $
$6,000
Form type
4
Date filed
12/7/2022, 07:00 AM
Previous filing
Nov 25, 2022
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $6K +120K +0.13% $0.05 90.6M Dec 6, 2022 Direct
holding OTLC Common Stock 16.8M Dec 6, 2022 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Dec 6, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 120,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on December 6, 2022 from the open market at a price of $0.05.